IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients

被引：0
作者：
Stefania Crucitta
Francesco Pasqualetti
Alessandra Gonnelli
Martina Ruglioni
Giovanna Irene Luculli
Martina Cantarella
Valerio Ortenzi
Cristian Scatena
Fabiola Paiar
Antonio Giuseppe Naccarato
Romano Danesi
Marzia Del Re
机构：
[1] University of Pisa,Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine
[2] University of Pisa,Radiation Oncology, Department of Medicine and Oncology
[3] University of Oxford,Department of Oncology
[4] University of Pisa,Division of Pathology, Department of Translational Research & New Technologies in Medicine & Surgery
[5] University of Milano,Department of Oncology and Hemato
来源：
BMC Cancer | / 24卷
关键词：
Liquid biopsy; cfDNA; IDH1; Glioma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 336 条
[1]  
Donaldson J(2018)Circulating tumor DNA: measurement and clinical utility Annu Rev Med 69 223-234
[2]  
Park BH(2018)Circulating tumor DNA assays in clinical Cancer research J Natl Cancer Inst 110 929-934
[3]  
Ossandon MR(2014)Liquid biopsies: genotyping circulating tumor DNA J Clin Oncol 32 579-586
[4]  
Agrawal L(2017)Liquid biopsy: current status and future perspectives Oncol Res Treat 40 404-408
[5]  
Bernhard EJ(2019)Liquid biopsy: general concepts Acta Cytol 63 449-455
[6]  
Conley BA(2013)Liquid biopsy: monitoring cancer-genetics in the blood Nat Rev Clin Oncol 10 472-484
[7]  
Dey SM(2017)Integrating liquid biopsies into the management of cancer Nat Rev Clin Oncol 14 531-548
[8]  
Divi RL(2020)Circulating tumor DNA testing-liquid biopsy of a Cancer JAMA Oncol 6 792-768
[9]  
Diaz LA(2022)ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO precision medicine working group Ann Oncol 33 750-C39
[10]  
Bardelli A(2020)Extracellular vesicles as biomarkers and therapeutic targets for cancer Am J Phys Cell Physiol 318 C29-28760
12345678910